EUVIMEDEUVIMED entdecken
Validierungsstudie

Identification of hypophosphatasia in adults with persistent hypophosphatasemia: clinical-genetic characterization and a validated diagnostic tool

Yazhao Mei, Ziyuan Wang, Na Ren, Li Shen, Xiang Li, Hua Yue, Hao Zhang, Jiemei Gu, Weiwei Hu, Jie Wang, Shanshan Li, Chao Gao und 10 weitere

Osteoporosis International · 2026

DOI: 10.1007/s00198-026-07986-8 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Osteoporosis International, 2026. Verfasst von Yazhao Mei und 21 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shang…. Hauptthemen laut MEDLINE: Hypophosphatasia. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study systematically analyzed 72 adults with genetically confirmed hypophosphatasia and compared them with 36 individuals with persistent hypophosphatasemia but negative ALPL variants. Using four routinely available indicators, a simplified diagnostic tool was developed and externally validated to facilitate the early identification of adult hypophosphatasia in clinical practice. PURPOSE: Hypophosphatasia (HPP), an underdiagnosed inborn error of disorder caused by ALPL mutations, poses diagnostic challenges in adults due to phenotypic heterogeneity. This study aimed to establish a large adult HPP cohort in China and develop a practical diagnostic tool using routine clinical parameters. METHODS: Clinical and genetic characteristics were systematically analyzed in 72 genetically confirmed adult HPP patients and 36 individuals with persistent hypophosphatasemia and negative ALPL genetic testing. Two models were developed to predict HPP: Model 0 (alkaline phosphatase (ALP)+pyridoxal-5'-phosphate (PLP)) and Model 1 (ALP+height Z-score+family history+chronic musculoskeletal pain). Model performance was evaluated by tenfold cross-validation, decision curve analysis (DCA) and external validation (n = 40, including 28 HPP). RESULTS: HPP patients exhibited lower ALP (27.0 (21.8, 33.3) U/L vs. 36.00 (32.0, 38.0) U/L; P < 0.001), elevated PLP (214.3 (121.3, 457.7) nmol/L vs. 42.6 (31.9, 63.5) nmol/L; P < 0.001), growth impairment, and higher prevalence of chronic musculoskeletal pain and family history. Optimal ALP and PLP cutoffs were 28.2 U/L and 114.9 nmol/L, respectively. Compound heterozygotes and crown domain variants in ALPL gene showed lower ALP and higher PLP levels. Model 1 performed comparably to Model 0 (AUC 0.918 vs. 0.896; P = 0.513), remained robust in the age-stratified sensitivity analysis (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypophosphatasiaHumansAlkaline PhosphataseAdultFemaleMaleMutationMiddle AgedPyridoxal PhosphateGenetic TestingYoung AdultBiomarkersAgedPhenotypeEarly Diagnosis

Stichwörter der Autor:innen

ALPL geneAlkaline phosphataseExternal validationHypophosphatasiaNomogramPyridoxal 5′ phosphate

Substanzen

Alkaline PhosphataseALPL protein, humanPyridoxal PhosphateBiomarkers

Autor:innen und Institutionen

  • Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Clinical Research Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Medical Examination Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Osteoporosis, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
  • Department of Endocrinology, Ningbo Fourth Hospital, Ningbo, Zhejiang, China.
  • Department of Stomatology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Mei, Y., Wang, Z., Ren, N., Shen, L., Li, X., Yue, H., Zhang, H., Gu, J., Hu, W., Wang, J., Li, S., Gao, C., Wei, Z., Xu, Y., Xu, S., Hong, W., Shi, Q., Wang, Y., Xu, J., …, & Wang, C. (2026). Identification of hypophosphatasia in adults with persistent hypophosphatasemia: clinical-genetic characterization and a validated diagnostic tool. Osteoporosis International. https://doi.org/10.1007/s00198-026-07986-8

Vancouver

Mei Y, Wang Z, Ren N, Shen L, Li X, Yue H, et al. Identification of hypophosphatasia in adults with persistent hypophosphatasemia: clinical-genetic characterization and a validated diagnostic tool. Osteoporosis International. 2026. doi:10.1007/s00198-026-07986-8

BibTeX
@article{Mei2026,
  author = {Mei, Yazhao and Wang, Ziyuan and Ren, Na and Shen, Li and Li, Xiang and Yue, Hua and Zhang, Hao and Gu, Jiemei and Hu, Weiwei and Wang, Jie and Li, Shanshan and Gao, Chao and Wei, Zhe and Xu, Yang and Xu, Shuqin and Hong, Wei and Shi, Qiongyao and Wang, Ya and Xu, Jing and Gao, Gao and Zhang, Zhenlin and Wang, Chun},
  title = {Identification of hypophosphatasia in adults with persistent hypophosphatasemia: clinical-genetic characterization and a validated diagnostic tool},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-07986-8}
}
Kostenlos starten →